Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


17th European Heart Disease and Heart Failure Congress

London, UK

Vladimir Ermoshkin

Vladimir Ermoshkin

Russian New University, Russia

Title: The new theory of heart failure


Biography: Vladimir Ermoshkin


Aim:C делана попытка нового анализа м еханизм а An attempt to study the mechanism of heart failure.


Method: Information search in the literature, participate in conferences, discussions with Russian leading cardiologists.


Result: Having heart failure means that for some reason your heart is not pumping blood around the body as well as it used to. Heart failure can be a major manifestation of virtually all diseases of the heart, including coronary atherosclerosis, myocardial infarction, acquired valvular disease, congenital heart disease, arrhythmias and cardiomyopathy. Populationbased echocardiographic studies have demonstrated that more than 50% of participants with left ventricular systolic dysfunction (generally defined as LVEF <35–40%) have no symptoms or signs of heart failure. How to interpret this data? How the heart can pump insufficient blood to one person and sufficient amount of blood to another? Where is the logic? The reason according to my theory of CVD is that, near liver, arteriovenous anastomoses (AVA) or cascade AVA opens for longer time than optimal. Veins overflow begin mechano-induced arrhythmia. Opened AVA lead to stagnation of blood in the area of small pelvis and ankle/feet. The other reasons are stasis of microcirculations, weight gain, varicose veins, endometriosis, prostatitis, hemorrhoids, thrombosis, and cancer. The development of these diseases is accompanied in most cases with heart failure.


Conclusions: It is necessary to correct the glaring errors in cardiology which are existing from past 50-100 years. It is necessary to develop pulse wave suppressors and artificial anastomosis with an adjustable diameter hole.



1.  British Heart Foundation is a registered Charity No. 225971. Internet resource.

2.  «ННПЦССХ им. А.Н. Бакулева» Минздрава России. Internet resource.

3.  Arend Mosterd, Arno W Hoes Clinical epidemiology of heart failure  Journal List Heart v.93(9); 2007 Sep

4.  Ermoshkin VI. New theory of arrhythmia. Conceptual substantiation of arrhythmia mechanisms. Cardiometry; Issue 8; May 2016; p.6–17; doi:10.12710/cardiometry.2016.8.617.

5.  Ermoshkin VI. A New Theory of Certain Cardiovascular Diseases. EC Cardiology, Volume 2 Issue 5 November 2016

6.  Ermoshkin V (2016) Pathological Role of the "Invisible" Anastomoses. J Bioengineer & Biomedical Sci 6: 209. doi: 10.4172/2155-9538.1000209

7.  Ermoshkin VI. Heart transplantation mysteriously eliminates arrhythmia. Cardiometry; Issue 8; May 2016; p.18–21; doi:10.12710/cardiometry.2016.8.1821.

8.  Ermoshkin VI. The mechanism of bronchial asthma. Why do the most serious asthma attacks occur at night? EC Cardiology, Volume 2 Issue 4 November 2016

9.  Ermoshkin VI. Proceedings of the International Conference on arrhythmia. [Abstract] Australia. Brisbane. Arrhythmia-2016, July 14-15, 2016, (Day 1, 16:45-17: 00).